Stay Informed on Corporate Sustainability
Explore industry news, insights, and updates from the Pharma Industry Awards.
Chemical Solutions Group acquires Celtic Water Care to expand industrial wastewater services
Irish chemical solutions provider CSG has acquired Cork-based wastewater specialist Celtic Water Care Solutions. The move strengthens CSG’s industrial wastewater capabilities, expands regional presence, and aligns with long-term growth plans targeting €150M revenue by 2030.
Gaelic Laboratories strengthens beta-lactam manufacturing through Athlone deal
Two Irish pharmaceutical manufacturers have consolidated their Beta-Lactam operations in a strategic acquisition. The deal strengthens Ireland’s life sciences manufacturing base and reinforces domestic supply chain resilience for essential generic antibiotics.
SGS Accelerates Viral Safety Testing with CHO uBH
SGS supports biomanufacturers with accelerated CHO uBH viral safety testing, combining GMP-compliant PCR technology, deep virology expertise and regulatory alignment to de-risk development and speed biologics to market.
AbbVie Ireland Wins Dual Awards at Pharma Industry Awards 2025
Looking back last year, AbbVie Ireland was named Pharma Company of the Year – Large and Biopharma Company of the Year at the Pharma Industry Awards 2025, recognised for its innovation, sustainability leadership, and people-focused culture as the sector looks toward 2026.
SGS ISL Expands Commercial Strength with Appointment of Lisa Collins as Business Development Lead
SGS ISL Ringaskiddy strengthens its commercial and client partnership capabilities with the appointment of Lisa Collins as Business Development Manager, bringing over 20 years of pharma and life sciences experience to support global demand for advanced analytical services, scientific collaboration, and high-quality client solutions.
Science Momentum
The pharma and life sciences sector is entering a period defined by strategic collaboration, capability expansion, and scientific innovation. This edition highlights initiatives that demonstrate how organisations are responding to evolving healthcare demands and global market dynamics. ‘SGS ISL expands commercial strength with appointment of Lisa Collins as Business Development Lead’ underscores the importance of commercial strategy in accelerating growth. The appointment reflects a sharpened focus on market engagement and the expanding demand for integrated life sciences services. In addition, 'Unlocking Scientific Capability with SGS Insourcing' highlights how internal capability expansion can enhance research agility and operational excellence. The initiative underscores the strategic value of strengthening scientific infrastructure to meet rising industry demands. Lastly, highlighting the sector’s top innovators, the 'Video Highlights of the Pharma Industry Awards 2025’ celebrate organisations and professionals driving research, operational excellence, and patient-focused initiatives, setting benchmarks for collaboration and impact and paving the way for the next wave of achievement at the 2026 awards. These stories illustrate a sector embracing collaboration, capability, and innovation. Organisations integrating these principles are positioned to deliver transformative, future-ready outcomes in pharma and life sciences.
Celebrating Pharma Innovation – Watch the Highlights
Relive the Pharma Industry Awards 2025 in the official highlights video, celebrating Ireland’s top pharmaceutical leaders, companies, and teams, while showcasing the ingenuity shaping the sector today.
Unlocking Scientific Capability with SGS Insourcing
Success in the life sciences sector depends on having the right expertise at the right moment. Rising regulatory requirements, complex development programmes, and operational pressures mean companies need more than traditional staffing solutions.
Denali secures 275m royalty funding agreement with Royalty Pharma
Denali secures $275m royalty funding from Royalty Pharma for tividenofusp alfa, supporting Hunter syndrome therapy development and TransportVehicle platform advancement ahead of FDA accelerated approval expected April 2026.
Rentschler Biopharma and Coriolis Pharma form strategic collaboration
Rentschler Biopharma and Coriolis Pharma form a strategic collaboration, offering end-to-end biopharmaceutical solutions from formulation to commercial manufacturing, accelerating product development and enhancing efficiency across the global biologics value chain.
Discover What's Happening
Explore our newsletters
Join our Newsletter to receive the latest industry trends, expert tips, and exclusive insights delivered straight to your inbox!


Sort by 


.png)

